California Bill Threatens 93% of Cannabis Beverage Sales

California's cannabis beverage sector faces an existential threat as Assembly Bill 2532 proposes slashing THC limits to 10mg per package, a move industry groups claim would eliminate 93% of current beverage sales. The legislation targets one of the fastest-growing segments in California's $5.2 billion legal cannabis market, where beverages have emerged as a key driver of mainstream consumer adoption.

The proposed cap represents a dramatic reduction from current regulations allowing up to 100mg THC per package for beverages. Industry data shows most popular cannabis drinks contain 20-50mg THC, positioning them well above the proposed threshold. This regulatory shift would force manufacturers to reformulate products or exit the market entirely, creating supply chain disruptions and potential job losses across cultivation, manufacturing, and retail operations.

California's beverage market has attracted major investments from multistate operators and consumer packaged goods companies betting on the category's crossover appeal. Companies like Canopy Growth and Constellation Brands have poured hundreds of millions into cannabis beverage development, viewing the format as critical for reaching alcohol consumers and health-conscious demographics. The proposed restrictions could undermine these strategic investments and slow institutional capital flows into the sector.

The timing proves particularly challenging as California's legal market already struggles against persistent illicit competition. Cannabis beverages command premium pricing due to complex manufacturing requirements and regulatory compliance costs. Forcing products into lower potency ranges could compress margins further while illegal operators continue selling unrestricted alternatives. This dynamic threatens to reverse recent gains in legal market share that state officials have worked to achieve.

Industry advocates argue the legislation contradicts California's broader cannabis normalization efforts and ignores consumer demand data showing preference for higher-potency options. The coalition's opposition highlights growing tensions between public health concerns and commercial cannabis interests as the industry matures. Legislative outcomes in California often influence regulatory approaches in other states, making AB 2532's progression critical for national beverage market development and investor confidence across the cannabis sector.